Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
2016
HIV/HCV Coinfection in Taiwan
Non-Antiretroviral Microbicides for HIV Prevention
Is It Time for Integrase Inhibitors to be the Preferred Regimen for the First-Line Treatment of HIV-1-Infected Naive Patients?
HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions
The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine
Body Fat Changes in People Living with HIV on Antiretroviral Therapy
NS5A Resistance: Clinical Implications and Treatment Possibilities
Mouse Models for Studies of In Vivo Functions of HIV-1 Nef
Drug Interactions with Cobicistat- or Ritonavir-Boosted Elvitegravir
HIV and HCV Therapies in 2016: Optimal Regimens